The highest competition rate ever in the KOSPI… General subscription 9-10 days
[한국투자증권 제공]
(Seoul = Yonhap News) Reporter Kim A-Ram = SK Bioscience, which is considered the main term for IPO in the first half of this year, has confirmed the public offering price at 65,000 won.
SK Bioscience announced on the 8th that as a result of the demand forecast for institutional investors conducted on the 4th to 5th, the public offering price was set at this price, which is the upper part of the desired range (band).
Accordingly, the amount of the public offering was decided at about 1.49 trillion won.
1,464 institutions participated in the demand forecasting, recording a competition rate of 1,275.47 to 1.
SK Biopharm, which was listed last year, is competitive.[326030](835.66 to 1) and Big Hit (1,117.25 to 1) higher than Kakao Games[293490]It was lower than (1,478.53 to 1).
In addition, after the introduction of the demand forecasting system to allocate publicly available stocks in 1999, the competition rate for demand forecasting in the securities market surpassed the Myeongshin Industries listed last year (1,196:1).
Most of the organizations participating in the demand forecasting, 1,406 (96.04%) offered a price of 65,000 won or more, which is the top of the band.
The number of applications from organizations that participated in the commitment of mandatory retention for a minimum of 15 days to a maximum of 6 months was calculated as 59.92% of the total number of applications.
Compared to the previously listed large fish stocks, it is less than SK Biopharm (81.15%) and is similar to Kakao Games (58.59%).
If the amount of commitments to hold obligatory holdings is small, the amount of institutional stocks to realize profits may be released if the stock price surges after listing.
General investor subscription is NH Investment & Securities from 9-10[005940], Korea Investment & Securities, Mirae Asset Daewoo[006800], SK Securities[001510], Samsung Securities[016360], Hana Financial Investment and other six securities companies.
Stocks allocated to general subscribers amount to 19,12,500 to 2295,000 shares, which is 25 to 30% of the total public offering.
SK Bioscience is scheduled to be listed on the stock market on the 18th.
Unauthorized reproduction-redistribution prohibited>
2021/03/08 16:40 sent